Calimot, Madel L.

HRN: 22-02-71  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/05/2024
CEFUROXIME 1.5GM (VIAL)
01/05/2024
01/05/2024
IV
1.5gram
Now
Imminent Abortion
Waiting Final Action 
01/05/2024
CEFUROXIME 750MG (VIAL)
01/05/2024
01/12/2024
IV
750mg
Q8hr
Imminent Abortion
Waiting Final Action 
01/05/2024
CEFUROXIME 1.5GM (VIAL)
01/05/2024
01/06/2024
IV
1.5g
Q8
IUFD; WBC 20.7
Waiting Final Action 
01/05/2024
CEFUROXIME 500MG (TAB)
01/06/2024
01/12/2024
PO
500mg
BId
IUFD; Wbc: 20.7
Waiting Final Action 
01/05/2024
CEFUROXIME 500MG (TAB)
01/06/2024
01/12/2024
PO
500mg
BId
IUFD; Wbc: 20.7
Waiting Final Action 
01/15/2024
CEFUROXIME 1.5GM (VIAL)
01/15/2024
01/15/2024
IVT
1.5 Gm
On Call Prior To OR
For D&C
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: